Clinical Trial Update: Prevention of Breast Cancer-related Lymphedma With Tacrolimus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial exploring tacrolimus for prevention of breast cancer-related lymphedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphedema

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Odense University Hospital | Conditions: Lymphedema | Phase 1, Phase 2 | Status: UNKNOWN